Will Garvin, shareholder in the firm's Life Sciences industry, authored "The Outlook on CBD: What Does 2020 Have in Store for the CBD Market?," published in BenefitsPro.
With a market estimated to grow more than 260% to a dizzying $1.25 billion over the next four years, it appears that the demand for cannabidiol, more commonly known as CBD, is expected to continue to grow. All of this growth is still expected despite the actions by the Food and Drug Administration (FDA).
Read the full article. (subscription required)